Cenobamate treatment of focal-onset seizures: Quality of life and outcome during up to eight years of treatment
Author:
Publisher
Elsevier BV
Subject
Behavioral Neuroscience,Neurology (clinical),Neurology
Reference16 articles.
1. Early identification of refractory epilepsy;Kwan;N Engl J Med,2000
2. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study;Chen;JAMA Neurol,2018
3. The impact of seizures on epilepsy outcomes: a national, community-based survey;Josephson;Epilepsia,2017
4. Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI);Bialer;Epilepsy Res,2013
5. US Food and Drug Administration. FDA approves new treatment for adults with partial-onset seizures, https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-adults-partial-onset-seizures/; 2019 [accessed 02 June 2020].
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effectiveness and Safety of Adjunctive Cenobamate in People with Focal-Onset Epilepsy: Evidence from the First Interim Analysis of the BLESS Study;Neurology and Therapy;2024-06-08
2. Efficacy and safety of adjunctive cenobamate based on patient etiology: Post-hoc analysis of YKP3089C017 randomized clinical trial;Seizure: European Journal of Epilepsy;2024-05
3. Greater need for treatment optimization in patients with epilepsy initiating adjunctive therapy: Results of a retrospective claims analysis of antiseizure medication drug load in the United States;Epilepsy & Behavior;2024-03
4. Reductions in concomitant antiseizure medication drug load during adjunctive cenobamate therapy: Post-hoc analysis of a subset of patients from a phase 3, multicenter, open-label study;Epilepsy Research;2024-02
5. New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System;CNS Drugs;2023-08-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3